Remove topics section-101
article thumbnail

5 Key Takeaways - Hot Topics in Biopharma: From Enablement to Written Description, Section 101 Challenges, and The Patent Eligibility Restoration Act of 2023

JD Supra Law

Kilpatrick Townsend recently held its semi-annual KTIPS (Kilpatrick Townsend Intellectual Property Seminar) in San Francisco.

article thumbnail

Announcing AIPLA article on Augmented Reality(AR) / Virtual Reality(VR): IP Aspects of Augmented Reality and Virtual Reality Technologies

LexBlog IP

Section 101 Issues (Subject Matter Eligibility) I look forward to working on this year’s upcoming paper to advance these topics further. The article can be found here and was published as part of the AIPLA’s INNOVATE Magazine. Subscribe to get updates to this post or to receive future posts from PatentNext.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Evolving Perspectives: USPTO Call for Comments on Patent Eligibility Comes to a Close (Part 1)

IPilogue

Patent and Trademarks Office (USPTO) closed the public comment period on the contentious topic of patent eligibility. While a vast realm of things can be patented, software and medical devices are frequently hot topics when discussing patent eligibility. On October 15, 2021, the U.S Current State. Significant U.S.

Patent 105
article thumbnail

The Federal Circuit hints at Enablement requirements for Artificial Intelligence (AI) Inventions

LexBlog IP

While the decision is nonprecedential, the case allows a window into the Federal Circuit’s analysis and treatment of artificial intelligence-type claims with respect to Section 112 issues such as enablement. This topic was recently previewed in Realtime Data v. Judge Newman did not analyze the claim under Section 112.

article thumbnail

CLE: Patent Focus: Section 101

Chicago IP

CT, the Intellectual Property Law Association of Chicago (IPLAC) is hosting a panel discussion focusing on topics related to Section 101. A selection of topics will be discussed. On May 6, 2021 from 12:00 p.m. – The panel is being moderated by A.

article thumbnail

ChromaDex Milk Vitamin Formulation Patents Soured by Section 101

Bio Law Blog

§ 101. § 101. Two weeks before trial, the district court granted Elysium’s motion for summary judgment under Section 101. Other courts have rejected Section 101 challenges to formulations of natural compounds. ChromaDex, Inc. Elysium Health, Inc. Civil Action No. 21, 2021) ( ChromaDex ).

Patent 52
article thumbnail

An Opinion on Chief Judge Moore’s Reported Unprecedented Effort to Remove Judge Newman

Patently-O

Judge Newman was eloquent, coherent, cogent, and spoke passionately about various topics, including section 101 (which requires a bit of mental agility, I would say). One, I saw Judge Newman (with Judge Lourie and former Judge O’Malley) speak at at the USPTO three weeks ago. (I I was there speaking on patent ethics.)